Brendan Teehan Sells 624 Shares of ACADIA Pharmaceuticals In

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) COO Brendan Teehan sold 624 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $24.67, for a total value of $15,394.08. Following the sale, the chief operating officer now owns 31,432 shares of the company’s […]

Related Keywords

Stifel Nicolaus , Brendan Teehan , Robertw Baird , Pharmaceuticals Daily , Needham Company , Sg Americas Securities , Td Asset Management Inc , Cantor Fitzgerald , Pharmaceuticals Inc , Acadia Pharmaceuticals Inc , Pharmaceuticals Stock Performance , Principal Financial Group Inc , Pharmaceuticals Company Profile , Barclays Plc , Nasdaq , Securities Exchange Commission , Charles Schwab Investment Management Inc , Get Free Report , Exchange Commission , Schwab Investment Management , Financial Group , Management Inc ,